Commercial Solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
White Paper
Do 340B Contract Pharmacies Really “Increase Access” for 340B Patients?
Dec 30, 2025
Stakeholders have long argued that 340B contract pharmacies expand access to medications. Our analysis finds no evidence that drug availability was impacted: while the number of contract pharmacies grew by 26%, fewer than 1% were closed, with no meaningful change following manufacturer policy implementation.
As courts and policymakers debate the future of 340B contract pharmacy rules, evidence, not assumption, is critical.
Discover how this analysis and insights help provide clarity for manufacturers, health systems, and policy leaders navigating an increasingly complex landscape.
Related solutions
Market Access
Gain high value access and increase the profitability of your brands
Brand & Marketing
Grow your brand, now and through patent expiry